Insights On Trial Design
-
Diversity In Clinical Trials: LGBTQIA+ Community Needs Not Just Allies, But Crusaders
9/9/2024
In an ACRP webinar on LGBTQIA+ diversity in clinical trials, industry panelists came together to discuss FDA action plans, SOGI data, advocacy efforts, challenges of transgender patients, and more.
-
Keeping Your Trials In Motion And Use AI Where It Makes Sense
2/2/2026
Explore the "pinball" approach used by the Judi platform that is giving stakeholders a distinct competitive advantage in the clinical trial landscape.
-
Key Risk Areas that Can Derail Clinical Trials with Ocular Endpoints
1/15/2025
By embracing point-of-need models and strategic collaborations, sponsors and CROs can streamline ophthalmic trials and maximize ROI while advancing sight-saving therapies.
-
Are Your Clinical Study Meetings Building Momentum, Or Wasting Time?
9/17/2025
Transforming passive clinical trial meetings into active catalysts for success, aligning teams and accelerating timelines.
-
Advantages Of Sourcing Biosimilars Vs. Branded Biologics In Clinical Trials
3/12/2026
Evaluate biosimilar alternatives during clinical trial planning to reduce comparator drug costs and improve overall study efficiency without compromising trial integrity.
-
Accelerating IND-Enabling Studies With Automated Bioanalysis Workflows
9/2/2025
Reimagined as automation-first, bioanalysis shifts from being an Investigational New Drug (IND) bottleneck to a catalyst for innovation—helping companies move therapies forward with greater confidence.
-
Site Networks And Hybrid Solutions
7/22/2025
Learn how community- and patient-centric site networks that have DCT capabilities are able to work with a broad-range of site types.
-
Solving Trial Enrollment Challenges With Direct-To-Patient Recruitment
1/6/2026
Overcome enrollment bottlenecks by shifting from site-centric models to tech-enabled, direct-to-patient outreach.
-
How High-Performing Trials Operationalize Health Equity Early
9/17/2025
Explore how embedding inclusion early in clinical development enhances enrollment, strengthens data integrity, and improves outcomes, especially in oncology and rare disease trials.
-
Faster Trial Planning and Site Selection
4/15/2025
Address the challenges of identifying the most suitable trial sites and investigators while optimizing feasibility planning, reducing screen failure rates, and improving patient retention.